What is mProbe?
mProbe Inc. operates at the forefront of biotechnology, dedicated to enhancing human health and wellness. The company leverages a proprietary technology platform that synergistically combines artificial intelligence with multi-omic diagnostics. This advanced integration aims to revolutionize the paradigm of disease prediction, prevention, and cure, positioning mProbe as a key player in the Precision Medicine, Precision Health, and Predictive Healthcare Analytics sectors. Their work is critical in developing more accurate and timely health interventions.
How much funding has mProbe raised?
mProbe has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for mProbe?
With the recent influx of capital and its classification as a large-scale, late-stage funding event, mProbe is strategically positioned for significant growth and market penetration. The 'major strategic investment' suggests strong confidence from backers in the company's long-term vision and technological capabilities. This funding will likely be directed towards scaling operations, further research and development of its AI-driven diagnostic tools, and expanding its market reach within the competitive biotechnology landscape. The company's focus on predictive healthcare analytics indicates a forward-thinking approach to tackling complex health challenges.
See full mProbe company page
